Daniel B. Carr

This profile gathers the share dealings of Daniel B. Carr in Javelin Pharmaceuticals, Inc. Over a trading history stretching from 22 November 2006 to 2 July 2010, the count stands at 11 filings.

Both buying and selling appear: 2 purchases worth €43k, against 3 sales worth €36k. The net balance comes to €6,488 on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants and 2 option exercises. So far in 2010, the count stands at no purchases and 3 sales.

The newest entry dates from 2 July 2010: a transaction of €142k, in Javelin Pharmaceuticals, Inc. The clock since the last published purchase (15 May 2008) now reads 6,735 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.